DETECTION OF TOXOPLASMA-GONDII IN VENOUS-BLOOD FROM AIDS PATIENTS BY POLYMERASE CHAIN-REACTION

被引:82
作者
DUPOUYCAMET, J
DESOUZA, SL
MASLO, C
PAUGAM, A
SAIMOT, AG
BENAROUS, R
TOURTESCHAEFER, C
DEROUIN, F
机构
[1] HOP ST LOUIS,PARASITOL MYCOL LAB,F-75011 PARIS,FRANCE
[2] INSERM,U332,INST COCHIN GENET MOLEC,F-75014 PARIS,FRANCE
[3] HOP BICHAT,SERV MALAD INFECT,F-75877 PARIS 18,FRANCE
关键词
D O I
10.1128/JCM.31.7.1866-1869.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Detection of Toxoplasma gondii in blood by means of the polymerase chain reaction (PCR) may facilitate the diagnosis and follow-up of cerebral toxoplasmosis in patients with AIDS. We evaluated this approach with seven patients with tissue culture-proven parasitemia, 14 patients with presumptive cerebral toxoplasmosis, and 17 healthy human immunodeficiency virus-positive controls. Each sample of blood was assayed on three different occasions by a PCR assay based on detection of the gene encoding the P30 surface protein. A positive PCR diagnosis required positivity in at least two of the three PCR tests. None of the controls had a positive PCR diagnosis, but six of the seven patients with parasitemia did. Cerebral toxoplasmosis was confirmed in 13 of the 14 patients with a presumptive diagnosis; diagnosis by PCR was positive before treatment for 9 of these 13 patients, whereas tissue culture was positive for only 1 patient. During treatment, blood samples were taken from 14 patients at regular intervals until day 12. PCR diagnosis became negative on ethidium-stained gels, but persistent signals were observed after hybridization, in some cases, for up to 12 days after initiation of therapy. PCR on venous blood could thus be a sensitive and noninvasive method for the diagnosis of cerebral and disseminated toxoplasmosis in AIDS patients and could be a potential tool for monitoring the effects of treatment.
引用
收藏
页码:1866 / 1869
页数:4
相关论文
共 28 条
  • [1] BOUGNOUX ME, 1990, PRESSE MED, V19, P1751
  • [2] BREZIN AP, 1991, NEW ENGL J MED, V324, P699
  • [3] BURG JL, 1988, J IMMUNOL, V141, P3584
  • [4] CONTRIBUTION OF A NEW PCR ASSAY TO THE PRENATAL-DIAGNOSIS OF CONGENITAL TOXOPLASMOSIS
    CAZENAVE, J
    FORESTIER, F
    BESSIERES, MH
    BROUSSIN, B
    BEGUERET, J
    [J]. PRENATAL DIAGNOSIS, 1992, 12 (02) : 119 - 127
  • [5] CRISTINA N, 1992, PATHOL BIOL, V40, P52
  • [6] TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS - A RANDOMIZED TRIAL COMPARING PYRIMETHAMINE PLUS CLINDAMYCIN TO PYRIMETHAMINE PLUS SULFADIAZINE
    DANNEMANN, B
    MCCUTCHAN, JA
    ISRAELSKI, D
    ANTONISKIS, D
    LEPORT, C
    LUFT, B
    NUSSBAUM, J
    CLUMECK, N
    MORLAT, P
    CHIU, J
    VILDE, JL
    ORELLANA, M
    FEIGAL, D
    BARTOK, A
    HESELTINE, P
    LEEDOM, J
    REMINGTON, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) : 33 - 43
  • [7] DEROUIN F, 1992, PRESSE MED, V21, P1853
  • [8] DEROUIN F, 1991, PATHOL BIOL, V39, P255
  • [9] LABORATORY DIAGNOSIS OF PULMONARY TOXOPLASMOSIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
    DEROUIN, F
    SARFATI, C
    BEAUVAIS, B
    ILIOU, MC
    DEHEN, L
    LARIVIERE, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (07) : 1661 - 1663
  • [10] COMPARATIVE-STUDY OF TISSUE-CULTURE AND MOUSE INOCULATION METHODS FOR DEMONSTRATION OF TOXOPLASMA-GONDII
    DEROUIN, F
    MAZERON, MC
    GARIN, YJF
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) : 1597 - 1600